Frequency of MBP and MBP peptide-reactive T cells in the HPRT mutant T-cell population of MS patients

Neurology

Volumn 46, Issue 5, 1996, Pages 1410-1415

  Lodge, Patricia A ^a,b   Johnson, Chad ^a   Sriram, Subramaniam ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b Vanderbilt Stallworth Rehabilitation Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN; MYELOPEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE FREQUENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE SCLEROSIS; MUTATION RATE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SOMATIC MUTATION; T LYMPHOCYTE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CELLS, CULTURED; FEMALE; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MUTATION; MYELIN BASIC PROTEINS; NERVOUS SYSTEM DISEASES; PEPTIDE FRAGMENTS; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 0029896195     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.46.5.1410     Document Type: Article

References (25)

1. McFarlin DE, McFarland HF. Multiple Sclerosis. N Engl J Med 1982;307:1183-1188.
2. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10: 153-187.
3. Liblau R, Tournier-Lasserve E, Maciazek J, et al. T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects. Eur J Immunol 1991;21:1391-1395.
4. Pette M, Fujita K, Kitze B, et al. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 1990;40:1770-1776.
5. Jingwu Z, Medaer R, Hashim GK, Chin Y, van den Berg-Loonen E, Raus JCM. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann Neurol 1992;32:330-338.
6. Chou YK, Bourdette DN, Offner H, et al. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 1992;38:105-114.
7. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990;346:183-187.
8. Sun J-B, Olsson T, Wang W-Z, et al. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 1991;21:1461-1468.
9. Olsson T, Zhi WW, Hojeberg B, et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ. J Clin Invest 1990;86:981-985.
10. Baars PA, Maurice MM, Rep M, Hooibrink B, van Lier RAW. Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+ CD45RA- CD27- T cell subset contains specialized primed T cells. J Immunol 1995;154:17-25.
11. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990;247:718-721.
12. Lodge PA, Allegretta M, Steinman L, Sriram S. Myelin basic protein peptide specificity and T-cell receptor gene usage of HPRT mutant T-cell clones in patients with multiple sclerosis. Ann Neurol 1994;36:734-740.
13. 12a. Smith ME. An in vitro system for study of myelin synthesis. J Neurochem 1969;16:83-98.
14. Mach B, Tiercy J-M. Genotypic typing of HLA class II: from the bench to the bedside. Hum Immunol 1991;30:278-284.
15. Nevinny-Stickel C, Bettionotti MdlP, Andrea A, et al. Nonradioactive HLA class II typing using polymerase chain reaction and digoxigenin-11-2′-3′-dideoxy-uridinetriphosphate-labeled oligonucleotide probes. Hum Immunol 1991;31:7-13.
16. Fazekas de St. Groth S. The evaluation of limiting dilution assays. J Immunol Methods 1982;49:R11-R23.
17. Kurtzke JF. Rating neurologic impairment in MS. Neurology 1983;33:1444-1452.
18. Richert JR, Reuben-Burnside CA, Deibler GE, Kies MW. Peptide specificities of myelin basic protein-reactive human T-cell clones. Neurology 1988;38:739-742.
19. Martin R, Jaraquemada D, Flerlage M, et al. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 1990;145:540-548.
20. Sriram S. Longitudinal study of frequency of HPRT mutant T cells in patients with multiple sclerosis. Neurology 1994;44: 311-315.
21. Tisch R, Yang X-D, Singer SM, Libau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366:72-75.
22. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-157.
23. Kaufman DL, Clare-Salzler M, Tian J, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69-72.
24. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993;11:729-766.
25. Su X-M, Sriram S. Analysis of TCR Vβ gene usage and encephalitogenicity of myelin basic protein peptide p91-103 reactive T cell clones in SJL mice: lack of evidence for V gene hypothesis. Cell Immunol 1992;141:485-495.